Year: 2021

VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, is pleased to report on its Amazon progress and plans: Following its stellar success on Amazon in the US, Else was recently invited by Amazon EU to launch a European unified account that will allow Else to sell its unique products on all of Amazon European marketplaces including the UK, Germany, France, Italy, Spain, the Netherland, and Sweden representing a market with over 300M people. Else already started the onboarding process with Amazon’s support and plans to launch its first European market in early 2022. “We’re very excited by this opportunity offered by Amazon EU,” said Hamutal Yitzhak, CEO &...

SAN FRANCISCO, CA, Nov. 18, 2021 (GLOBE NEWSWIRE) — Wikisoft Corp. (the “Company,” “we,” and “our”) (OTCQB: WSFT) — In 2017, the fledgling Wikisoft had a big vision – help businesses large and small in a big way. Our founders’ goal was to create a company information database and then share the information to help small companies grow big. Since then, the company has grown, added world class executives to the C-level team and invested heavily into Big Data technology to fulfill the founders’ vision. It seems the strategy was well-chosen. Here are three facts to justify it: The global big data technology market size was $41.33 billion in 2019 and is projected to reach $116.07 billion by 2027, at a CAGR of 14.0% in forecast period according to a report published by Fortune Business Insights,...

PITTSBURGH, Nov. 18, 2021 (GLOBE NEWSWIRE) — L.B. Foster Company (NASDAQ: FSTR) and Investor Relations firm, Lytham Partners will host a Virtual Investor Day on December 14th, 2021, starting at 11:00 a.m. Eastern Time. John Kasel, President and Chief Executive Officer, Bill Thalman, Senior Vice President and Chief Financial Officer, and other members of the senior management team will provide an in-depth review of the Company’s business and growth strategies, including innovation through new products and technology. A live webcast of the presentations, including a Q&A section, will be available the day of the event through L.B. Foster’s Investor Relations Page. Registration for the event is required and can be completed in advance on the Investor Day 2021 Registration Site. If you would like to submit questions prior to the...

Kaltura’s primary cloud provider, AWS, fuels the rapid growth of the Kaltura Video Experience Cloud NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) — Today, Kaltura (NASDAQ: KLTR), the Video Experience Cloud, announced that it is extending its longstanding work with Amazon Web Services, Inc. (AWS) as its primary cloud provider to support its rapid growth, leveraging the breadth and depth of AWS services including compute, storage, network & content delivery, analytics, containers, and media services. As part of this announcement, Kaltura shares that it has joined the AWS Independent Software Vendor (ISV) Accelerate Program. As a member of the AWS ISV Accelerate Program, Kaltura is able to co-sell with the AWS Sales organization to accelerate sales cycles and drive new business. Following its acceptance into the AWS ISV Accelerate...

HAMILTON, New Zealand, Nov. 18, 2021 (GLOBE NEWSWIRE) — Smokefree Innotec, Inc. (OTC: SFIO), a leading asset management company and innovation group, is pleased to share news of its recent strategic acquisitions in line with its five-year roadmap of global expansion in the fields of franchising, food manufacturing and distribution, coffee, property development, and technology and software development. ______________________________________ Jeths Lacson, CEO / Chairman, shared the following letter regarding the company’s Q3 report: “Dear shareholders and valued business partners, In the last letter I addressed to you, I outlined a number of projects we had in development for Smokefree Innotec, Inc (SFIO). I am thrilled to share that we have not only accomplished many of the key milestones we had set for the Company since then, but...

Englewood Cliffs NJ, Nov. 18, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner Zylo Therapeutics received its first ketamine shipment and initiated loading ketamine into their Z-Pod® transdermal technology. Eric Weisblum, CEO of Silo Pharma stated “The commencement of Novel Ketamine loaded Z-Pods  is a pivotal advancement for administering Ketamine as a therapeutic with the patented Z-Pod® technology.  This important milestone for Silo will help us study the benefits of slow-release transdermal release of Ketamine.  The delivery and loading accelerates the development to deliver Ketamine as a therapeutic and potentially Psilocybin in a time-released or dosage-controlled manner.” About...

New York, Nov. 18, 2021 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with two institutional investors (the “Holders”) to sell certain senior secured convertible notes of the Company in a private placement in the aggregate principal amount of $7,800,000 in the aggregate original principal amount of $6,500,000, representing an aggregate original issue discount of 20% (the “Convertible Notes”). The Convertible Notes do not bear interest except upon the occurrence of certain events of default. Pursuant to the SPA, the Convertible Notes will be issued to the Holders, together with 4-year warrants to acquire 1,800,000 shares of the Company’s common stock (the...

Second Phase 3 Study is Designed to Evaluate Safety and Efficacy of Simufilam Over 78 Weeks in 1,000 Patients with Alzheimer’s Disease AUSTIN, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company, announced today it has initiated a second Phase 3 study of simufilam, the Company’s investigational drug for patients with Alzheimer’s disease. This second Phase 3 study is designed to evaluate the safety and efficacy of simufilam over 78 weeks in approximately 1,000 patients with Alzheimer’s disease across clinical sites in the U.S. and Canada. “Alzheimer’s disease isn’t going away anytime soon, and neither are we,” said Remi Barbier, President & CEO. “Developing a new drug solution for Alzheimer’s is a daunting task during the best of times. During these times of outlandish allegations...

STAMFORD, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) — Kroll Bond Ratings Agency (“KBRA”) assigned a preliminary deposit and issuer rating of BBB, and preferred stock rating of BBB- to the digital-first national bank being created by the proposed merger of American Challenger Development Corp. (“American Challenger”) with Patriot National Bancorp, Inc. (“Patriot”) (NASDAQ: PNBK), the holding company of Patriot Bank, N.A., a national bank headquartered in Stamford, Connecticut. “The contribution of common equity from the parent is projected to create significant overcapitalization and common equity cushion below the preferred stock while the bank transitions to a stabilized business profile,” Kroll declared. They concluded, “Underpinning the ratings is KBRA’s favorable view of the depth and expertise of management.” While the assigned...